Methods and clinical biomarker discovery for targeted proteomics using Olink technology
PROTEOMICS – Clinical Applications · 2024-09 · 18 (5)
DOI: 10.1002/prca.202300233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PROTEOMICS – Clinical Applications, online erschienen am 10.05.2024. Verfasst von Han Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Proteomics, Biomarkers. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: Medical Scientific Research Foundation of Zhejiang Province, China, Zhejiang Provincial Public Service and Application Research Foundation, China, Key Program of Ningbo Natural Science Foundation, China.
Abstract (Originalsprache)
Purpose
This paper is to offer insights for designing research utilizing Olink technology to identify biomarkers and potential therapeutic targets for disease treatment. Experimental Design We discusses the application of Olink technology in oncology, cardiovascular, respiratory and immune‐related diseases, and Outlines the advantages and limitations of Olink technology.
Results
Olink technology simplifies the search for therapeutic targets, advances proteomics research, reveals the pathogenesis of diseases, and ultimately helps patients develop precision treatments.
Conclusions
Although proteomics technology has been rapidly developed in recent years, each method has its own disadvantages, so in the future research, more methods should be selected for combined application to verify each other.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Epidemiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
- Center for Cardiovascular and Cerebrovascular Epidemiology and Translational Medicine, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China.
- Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
- Shen zhen Nanshan Center for Chronic Disease Control, Shenzhen, Guangdong, China.
- Department of Anus & Intestine Surgery, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
- Department of Rehabilitation Medicine, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
ORCID-Profile: Liyuan Han
Förderung
- Medical Scientific Research Foundation of Zhejiang Province, China
- Zhejiang Provincial Public Service and Application Research Foundation, China
- Key Program of Ningbo Natural Science Foundation, China
- Ningbo Leading Top Talent Training Project
- Internal Fund of Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences
- HwaMei Reasearch Foundation of Ningbo No.2 Hospital
- Ningbo Health Technology Project
- Ningbo Key Research and Development Plan Project
Zitieren
APA
Wang, H., Zhao, T., Zeng, J., Zhang, R., Pu, L., Qian, S., Xu, S., Jiang, Y., Pan, L., Dai, X., Guo, X., & Han, L. (2024). Methods and clinical biomarker discovery for targeted proteomics using Olink technology. PROTEOMICS – Clinical Applications, 18(5). https://doi.org/10.1002/prca.202300233
Vancouver
Wang H, Zhao T, Zeng J, Zhang R, Pu L, Qian S, et al. Methods and clinical biomarker discovery for targeted proteomics using Olink technology. PROTEOMICS – Clinical Applications. 2024;18(5). doi:10.1002/prca.202300233
BibTeX
@article{Wang2024,
author = {Wang, Han and Zhao, Tian and Zeng, Jingjing and Zhang, Ruijie and Pu, Liyuan and Qian, Suying and Xu, Shan and Jiang, Yannan and Pan, Lifang and Dai, Xiaoyu and Guo, Xu and Han, Liyuan},
title = {Methods and clinical biomarker discovery for targeted proteomics using Olink technology},
journal = {PROTEOMICS – Clinical Applications},
year = {2024},
volume = {18},
number = {5},
doi = {10.1002/prca.202300233}
}
EUVIMED